- Home
- The School
- Study
- Allocations Information
- FAQ
- Research
- Maternity, Families and Primary Care
- Ageing Integrated Research
- Enhancing Cancer Awareness & Survivorship Programmes (ECASP)
- Centre for Safer Staffing and Healthcare Systems Research (The CATALYST Centre)
- J.U.S.T.I.C.E in Healthcare: Just, Universal, Sustainable, Trusted, Inclusive, Caring, & Ethical healthcare in life and death
- Mental Health and Wellbeing for the 21st Century: People, Organisations, and Places
- School of Nursing and Midwifery Scholarly Impact Reports
- SURE Awards
- Research and Innovation Hub
- Current Students
- Conferences & Events
News
Irish Cancer Society Survivorship Project of the Year Award for the Linking You to Support and Advice (LYSA) study
Members of the Cancer Research @UCC team were honoured with the Irish Cancer Society Survivorship Project of the Year Award (2025)
Members of the Cancer Research @UCC team were honoured with the Irish Cancer Society Survivorship Project of the Year Award (2025) for their Linking You to Support and Advice (LYSA) study at the Irish Cancer Society Research Awards in Dublin on Thursday, February 20th, 2025, recognising their innovative approach to survivorship care for women recovering from cancer.
The Irish Cancer Society introduced the Survivorship Project of the Year category this year to highlight outstanding contributions in cancer survivorship research. The LYSA study, a collaboration between UCC’s School of Nursing & Midwifery and Cancer Research @UCC, stood out for its focus on patient-centred, nurse-led supportive care for women recovering from breast and gynaecologic cancers.
LYSA was a parallel arm randomized controlled trial (RCT) which examined the feasibility of delivering a Cancer Survivorship Clinic. The electronic patient-reported outcome (ePRO) assessments were an innovative symptom monitoring system which helped to detect the treatment-related effects and provides individualized support for cancer survivors. The study nurse and dietician provided support as needed to experimental arm participants. The experimental arm participants had better quality of life and better symptom scores at study end relative to the comparator arm. The findings will provide direction for the implementation of future survivorship care in an Irish context.
LYSA was a true team effort, and the team included:
CUH/UCC team: Roisin M. Connolly (PI), Josephine Hegarty (Co-PI), Kate O’Connell, Katie Johnston, Laia Raigal-Aran, Andrea Davis, Darren Dahly, Brendan Palmer, Katie Bermingham, Katarina Medved, Noreen Kearns, Seamus O’Reilly, Dearbhaile C. Collins, Mark Corrigan, John Coulter, Vicki Cleary, Samantha Cushen, Aileen Flavin, Fiona Byrne, Aisling O’Grady, Sinead Noonan, Deirdre O’Neill, Aileen Murphy
UHG/UOG team: Veronica Bridget McInerney, Aoife Lowery, Rebecca Moore, Veronica McSharry, Ruth Kilcawley and colleagues
Key partners: PPI collaborators, key stakeholders, funders (Irish Cancer Society, Breakthrough Cancer Research and Pfizer).